CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Neuro-Worlddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04920123
NCT04920123N/ACompleted
CompareCT.gov

Towards the Development of a Mobile-health Technology Designed to Encourage the Use of Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

University of Massachusetts, Amherst·interventional·Posted Jun 9, 2021·Updated Aug 7, 2025

In Brief

A clinical study evaluating Neuro-World for Mild Cognitive Impairment. Completed, enrolled 19 participants across 2 sites.

Detailed Summary

This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMild Cognitive Impairment
CountriesUnited States
CollaboratorsRutgers, The State University of New Jersey, Université de Montréal

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJun 9, 2021
Enrollment StartFeb 17, 2022
Primary CompletionMar 31, 2025
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 5.1 years ago

Interventions

Neuro-Worlddevice

Neuro-World is a collection of six games that are developed for cognitive training that focuses on memory and attention.